Company Filing History:
5 out of 10 
5 out of 12 
3 out of 135 
Years Active: 1993-2020
Title: **Christopher M. Starr: Innovator in Enzyme Delivery Systems**
Introduction
Christopher M. Starr, based in Sonoma, CA, is a distinguished inventor with a remarkable portfolio consisting of 19 patents. His innovative work primarily focuses on therapeutic applications related to lysosomal storage diseases, showcasing his commitment to advancing medical science and improving patient outcomes.
Latest Patents
Among his latest inventions, one notable patent addresses the use of P97 as an enzyme delivery system for delivering therapeutic lysosomal enzymes. This invention provides compositions and methods for treating, ameliorating, or preventing lysosomal storage diseases by administering a P97 conjugated with an enzyme capable of penetrating lysosomes, even across the blood-brain barrier. Another significant contribution involves compositions comprised of receptor-associated protein (RAP) variants that are specific for CR-containing proteins. This patent details methods for generating receptor-selective RAP variants and outlines their therapeutic applications.
Career Highlights
Christopher has contributed his expertise and innovative spirit to prominent companies in the biotechnology sector. Notable organizations include Glyko, Inc. and Raptor Pharmaceuticals Inc. Through these positions, he has played a crucial role in developing groundbreaking technologies to address critical health issues.
Collaborations
Throughout his career, Christopher has collaborated with esteemed professionals such as Todd C. Zankel and Minmin Qin. These partnerships have further facilitated the exchange of ideas and innovation, amplifying the impact of their collective work in the field.
Conclusion
Christopher M. Starr is a testament to the power of innovation in biotechnology. With his extensive portfolio and impactful collaborations, he continues to drive advancements in therapeutic solutions, positioning himself as a leading figure in the realm of medical inventions. His work not only reflects his ingenuity but also his dedication to enhancing the quality of life for patients affected by lysosomal storage diseases.